Dar-Bin Shieh, deputy minister of science and technology of the Republic of China (Taiwan), gives an overview of Biomedical Industry Innovation Program, enacted to bolster Taiwan’s biomedical and biotechnology sectors as part of the 5+2 Industrial Innovation Plan. Deputy Minister Shieh also elaborates on how Taiwan’s unique strengths in ICT, infrastructure, and talent will help drive forward the country’s position as a hub of R&D innovation in the Asia Pacific region.
Since 2008, investment in the [Taiwanese] biotech industry has been growing steadily
